AcquisitionOther
Adial Pharmaceuticals, Inc. acquired Azora Therapeutics, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Adial Pharmaceuticals, Inc. -> Azora Therapeutics, Inc. · $32 million
Bring colon-targeted AhR agonist AT177 into pipeline for ulcerative colitis treatment.
Open source record (SEC) ↗